Investor

BioMedPartners AG

Last cheque observed Sep 2023. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series A

Cheques on record
0%of best year0cheques in 12 months, 1 on record
Since the last cheque1151days00hrs00min00sec
Median round$38MRounds led1 of 1
Pitch BioMedPartners AG

BioMedPartners AG highlights

  1. 01

    1 rounds on record

  2. 02

    Mostly Series A: 100% of its rounds

  3. 03

    Led 1 rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first1 appearances

  1. 2023

    1 round

  2. Sept
    TOLREMO therapeuticsSeries A · CH · Firms' own news pages$38MLed

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Recently backed

The latest companies BioMedPartners AG put money into.

TOLREMO therapeutics$38M · Sept 2023

Quick answers about BioMedPartners AG

What does BioMedPartners AG invest in?

BioMedPartners AG invests most often at Series A (100% of the rounds on record).

How active is BioMedPartners AG?

1 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Sept 2023.

What has BioMedPartners AG invested in recently?

Its most recent investments on record: TOLREMO therapeutics (Series A, Sept 2023).

How big are BioMedPartners AG's cheques?

The median round it joins is $38M.

Is BioMedPartners AG investing now?

No investments in the last 12 months; the latest was in Sept 2023.

What kind of investor is BioMedPartners AG?

BioMedPartners AG is a VC firm.

Where does this information on BioMedPartners AG come from?

From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it